U.S. stocks swing on analyst calls, deal news and restructuring concerns

Traders Union
All News
Stocks
U.S. stocks swing on news

Highlights

Lockheed Martin gains 3% after Morgan Stanley upgrades to overweight and lifts its price target to $835, citing F-35 production momentum.
Surgery Partners soars 47% as Bon Secours Mercy Health announces a $23.50 per share cash buyout, valuing the company at $5.7 billion.
JetBlue Airways plunges 12% after reports that senior creditors are working with a restructuring adviser amid a roughly 50% year-to-date stock decline.

Analyst upgrades and corporate updates move key names

As reported by CNBC, several of the session's biggest stock moves are following broker rating changes and company-specific developments rather than broad market factors.

Lockheed Martin gains 3% after Morgan Stanley upgrades the defense contractor to overweight from equal weight and raises its 12-month price target to $835 from $690, pointing to continued F-35 fighter jet production for the Defense Department. CACI International jumps 6% after Jefferies lifts its rating to buy from hold and raises its price target to $725, implying nearly 17% upside from Friday's close.

Verizon Communications falls 3% after reporting third-quarter earnings. Tesla climbs 6% after Barclays upgrades the electric vehicle maker to overweight, saying a potential merger opportunity with SpaceX, growth in the Robotaxi business and strength in its core operations improve the outlook.

Booz Allen Hamilton rises 8% after TD Cowen upgrades the stock to buy from hold with a $95 price target, citing stronger funded backlog, federal civilian sales and fixed-price trends. Ross Stores adds 3% after UBS upgrades the retailer to buy, with analysts saying improving store productivity could push the stock above $300.

Xencor surges 20% to a 52-week high of $30 after presenting positive data on a therapy for certain kidney cancers. The biotech says XmAb819 shows anti-tumor activity in patients with advanced clear cell renal cell carcinoma, and that existing cash reserves are enough to fund pipeline research and operations into 2029.

Deal activity and credit concerns reshape sector sentiment

Merger announcements and restructuring fears are also driving sharp divergences across healthcare, energy, transport and technology-linked names.

Surgery Partners soars 47% after Bon Secours Mercy Health agrees to a buyout worth $23.50 a share in cash, valuing the company at $5.7 billion. Range Resources rises 15% after EQT Corp says it will acquire the natural gas producer in an all-stock transaction valuing Range at more than $50 billion, while EQT shares fall 4%; the deal is expected to close in the first quarter of 2027.

JetBlue Airways tumbles 12% after The Wall Street Journal reports that senior creditors are working with a restructuring adviser. The New York-based airline's bond prices sink late last week, and the stock is down about 50% year to date.

Moderna slips another 2% as selling pressure continues after leaked results from a closely watched cancer vaccine study last Thursday. Fair Isaac drops 14% after Wells Fargo downgrades the stock to equal weight from overweight, saying the decision not to raise prices is aimed at keeping lenders on its FICO score platform.

Among cloud infrastructure names, CoreWeave and Iren rebound 5% and Nebius gains 1% after Elon Musk writes on X that more than 200 neoclouds are set to face sharp competitive pressure. Maplebear, the parent of Instacart, falls nearly 6% after The Information reports on Friday that the company has been exploring a sale, including early-stage talks with DoorDash and Uber.

Our earlier article on the S&P 500’s push toward 8,000 explained how the index’s midsummer advance has been heavily driven by AI-linked megacaps, leaving investors focused on whether third-quarter earnings can justify valuations amid higher oil prices, elevated Treasury yields, and political uncertainty. It also highlighted weakening market breadth and concentration risk, with many index components lagging even as headline levels stayed near records.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.